When it comes to clinical trials, the consequences of bad data can be severe. Research and development becomes complicated and lives can be put at risk. The need for clean clinical data is critical for comprehensive reporting and analysis, ultimately enabling safer drugs and devices to be brought to market faster. Join us this Thursday […]
Blogs from this Author
Sites Ask Sponsors And CROs, “Where’s The Love?”
According to the 2016 Summit Site Landscape Survey, which was conducted by the Society for Clinical Research Sites, the majority of clinical sites aren’t feeling the love from sponsors and CROs. Of the 463 survey respondents, only 31% felt their relationship with sponsors had improved in the past two years, and only 25% felt that […]
Top 5 Life Sciences Blog Posts From November 2016
Now that December is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in November – they’re ranked in order of popularity, with number one being the most viewed piece. 10 Headlines That Suggest Donald Trump […]
Introduction To Digital Transformation In Financial Services
We have become a digital society. We use mobile devices to guide us through rush hour traffic, to find a great new spot for lunch, to research recipes for dinner, to do our shopping, to track our exercise, to entertain, to connect with friends and family, and to wake us up the next morning to […]
Eli Lilly Launched 50+ Apps On Salesforce
As one of Salesforce’s strategic partners, I’m glad to share the success Eli Lilly is having with the Salesforce platform. According to a press release that was issued by Salesforce, the pharmaceutical company has launched 50+ internal and external applications over the last two years. TrialGuide is one example. The website, which is naturally mobile-friendly, […]
European Millennials Hungry For (Good) Mobile Payment Technology
A new report published by Ipsos MORI, a market research company, and VocaLink, a global payments partner to financial institutions and governments, indicates that European millennials are struggling to adopt mobile payment technology. While more than half of the ~4,000 millennials from Germany, Italy, UK, and the Netherlands that took part in the study exhibit deep […]
Facebook Tells Insurer It’s Not OK To Leverage Users’ Posts For Pricing
A recent Financial Times article discussed how Admiral, a UK-based insurance company, was planning to leverage Facebook data to offer policy discounts. “The way you write and the things you post online are shaped by your personality,” an Admiral employee said. “An overconfident person will use phrases such as ‘always,’ ‘never,’ and exclamation marks rather […]
[This Week] Mining The Internet For Safety Signals
Online communities and social networks like Twitter and Facebook have become important real-world data repositories that can be leveraged by life sciences organizations to gain insight into the patient experience, as well as to identify potential safety issues related to drugs and devices – otherwise known as safety signal detection. This week, my colleague, Dr. […]
10 Headlines That Suggest Donald Trump Is Good For Pharma
This year’s presidential election invoked serious fear in the pharmaceutical industry, with the cost of drugs taking center stage for a good portion of some candidates’ campaigns. While what candidates say they’ll do could very well be different than what they’ll try to do, their words and records are enough to push pundits, investors, and […]
Here’s The Post-Election Letter From Jamie Dimon To JPMorgan Colleagues
As the world reflects on the tumultuous presidential election, some company executives have quickly come out to share their perspectives. Jamie Dimon, JPMorgan’s Chairman of the Board and CEO, has written a letter to company employees with a message of hope and a call to come together. The letter is also posted on JPMorgan’s homepage. We […]
Standards And Collaboration Can Help FSIs Survive Regulatory Fatigue
Tim Lind, global head of financial regulatory solutions, Thomson Reuters, sat down with Finextra at Sibos, the annual conference organized by SWIFT, to discuss the challenges financial services institutions face when it comes to regulatory change. To the put the regulatory climate in better perspective, Mr. Lind pointed out a few facts: Over the last […]
Will We See More Advertising From Pharma On Facebook?
Bayer recently launched its first Facebook ad. The ad also happens to be the first time Facebook has allowed a company to put important safety information (ISI) in a scrolling format, something that pharmaceutical companies have long been able to do in banner ads. In addition, the social media giant is also enabling drug companies […]